These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24100029)

  • 21. Novel splicing mutation in the NEMO (IKK-gamma) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation.
    Ørstavik KH; Kristiansen M; Knudsen GP; Storhaug K; Vege A; Eiklid K; Abrahamsen TG; Smahi A; Steen-Johnsen J
    Am J Med Genet A; 2006 Jan; 140(1):31-9. PubMed ID: 16333836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura.
    Ramírez-Alejo N; Alcántara-Montiel JC; Yamazaki-Nakashimada M; Duran-McKinster C; Valenzuela-León P; Rivas-Larrauri F; Cedillo-Barrón L; Hernández-Rivas R; Santos-Argumedo L
    Clin Immunol; 2015 Oct; 160(2):163-71. PubMed ID: 26117626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation.
    Rahighi S; Ikeda F; Kawasaki M; Akutsu M; Suzuki N; Kato R; Kensche T; Uejima T; Bloor S; Komander D; Randow F; Wakatsuki S; Dikic I
    Cell; 2009 Mar; 136(6):1098-109. PubMed ID: 19303852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
    Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
    Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NEMO oligomerization and its ubiquitin-binding properties.
    Ivins FJ; Montgomery MG; Smith SJ; Morris-Davies AC; Taylor IA; Rittinger K
    Biochem J; 2009 Jun; 421(2):243-51. PubMed ID: 19422324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
    Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
    Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid phase separation of NEMO induced by polyubiquitin chains activates NF-κB.
    Du M; Ea CK; Fang Y; Chen ZJ
    Mol Cell; 2022 Jul; 82(13):2415-2426.e5. PubMed ID: 35477005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired dendritic-cell function in ectodermal dysplasia with immune deficiency is linked to defective NEMO ubiquitination.
    Temmerman ST; Ma CA; Borges L; Kubin M; Liu S; Derry JM; Jain A
    Blood; 2006 Oct; 108(7):2324-31. PubMed ID: 16794254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO.
    Carrol ED; Gennery AR; Flood TJ; Spickett GP; Abinun M
    Arch Dis Child; 2003 Apr; 88(4):340-1. PubMed ID: 12651765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency.
    Kawai T; Nishikomori R; Heike T
    Allergol Int; 2012 Jun; 61(2):207-17. PubMed ID: 22635013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel missense mutation in the nuclear factor-κB essential modulator (NEMO) gene resulting in impaired activation of the NF-κB pathway and a unique clinical phenotype presenting as MRSA subdural empyema.
    Devora GA; Sun L; Chen Z; van Oers NS; Hanson EP; Orange JS; de la Morena MT
    J Clin Immunol; 2010 Nov; 30(6):881-5. PubMed ID: 20652730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes.
    Smahi A; Courtois G; Rabia SH; Döffinger R; Bodemer C; Munnich A; Casanova JL; Israël A
    Hum Mol Genet; 2002 Oct; 11(20):2371-5. PubMed ID: 12351572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
    Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
    Courtois G; Smahi A; Reichenbach J; Döffinger R; Cancrini C; Bonnet M; Puel A; Chable-Bessia C; Yamaoka S; Feinberg J; Dupuis-Girod S; Bodemer C; Livadiotti S; Novelli F; Rossi P; Fischer A; Israël A; Munnich A; Le Deist F; Casanova JL
    J Clin Invest; 2003 Oct; 112(7):1108-15. PubMed ID: 14523047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncanonical NF-κB signaling is limited by classical NF-κB activity.
    Gray CM; Remouchamps C; McCorkell KA; Solt LA; Dejardin E; Orange JS; May MJ
    Sci Signal; 2014 Feb; 7(311):ra13. PubMed ID: 24497610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation of nonessential cysteines shows that the NF-κB essential modulator forms a constitutive noncovalent dimer that binds IκB kinase-β with high affinity.
    Cote SM; Gilmore TD; Shaffer R; Weber U; Bollam R; Golden MS; Glover K; Herscovitch M; Ennis T; Allen KN; Whitty A
    Biochemistry; 2013 Dec; 52(51):9141-54. PubMed ID: 24266532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The zinc finger of NEMO is a functional ubiquitin-binding domain.
    Cordier F; Grubisha O; Traincard F; Véron M; Delepierre M; Agou F
    J Biol Chem; 2009 Jan; 284(5):2902-2907. PubMed ID: 19033441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression in nuclear factor-κB essential modulator due to a novel splice-site mutation causes X-linked ectodermal dysplasia with immunodeficiency.
    Karakawa S; Okada S; Tsumura M; Mizoguchi Y; Ohno N; Yasunaga S; Ohtsubo M; Kawai T; Nishikomori R; Sakaguchi T; Takihara Y; Kobayashi M
    J Clin Immunol; 2011 Oct; 31(5):762-72. PubMed ID: 21720903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia.
    Niehues T; Reichenbach J; Neubert J; Gudowius S; Puel A; Horneff G; Lainka E; Dirksen U; Schroten H; Döffinger R; Casanova JL; Wahn V
    J Allergy Clin Immunol; 2004 Dec; 114(6):1456-62. PubMed ID: 15577852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology.
    Gautheron J; Pescatore A; Fusco F; Esposito E; Yamaoka S; Agou F; Ursini MV; Courtois G
    Hum Mol Genet; 2010 Aug; 19(16):3138-49. PubMed ID: 20529958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.